Fund Holdings — Vestal Point Capital, LP

Total Portfolio Value:
$1.69B
Total Bought:
$810.97M
Total Sold:
$370.86M
Net Transaction:
+$440.11M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Jazz Pharmaceuticals plcSHS USD(JAZZ)900,000975,000+75,000$100.27M$120.07M7.12%+$19.80M
Cytokinetics, Incorporated(CYTK)1,500,0002,350,000+850,000$79.20M$110.54M6.55%+$31.34M
Merck & Co., Inc.(MRK)0800,000+800,000$0$79.58M4.72%+$79.58M
Ascendis Pharma A/SADR(ASND)250,000520,000+270,000$37.33M$71.59M4.24%+$34.26M
Ultragenyx Pharmaceutical Inc.(RARE)750,0001,500,000+750,000$41.66M$63.10M3.74%+$21.44M
Insmed Incorporated(INSM)1,600,000900,000-700,000$116.80M$62.14M3.68%-$54.66M
BioMarin Pharmaceutical Inc.(BMRN)400,000860,000+460,000$28.12M$56.53M3.35%+$28.41M
uniQure N.V.SHS(QURE)4,750,0003,025,000-1,725,000$23.42M$53.42M3.17%+$30.00M
Soleno Therapeutics Inc720,0001,060,000+340,000$36.35M$47.65M2.82%+$11.29M
Nuvalent Inc0600,000+600,000$0$46.97M2.78%+$46.97M
Structure Therapeutics IncADS1,150,0001,725,000+575,000$50.47M$46.78M2.77%-$3.69M
Vera Therapeutics, Inc.CL A(VERA)01,075,000+1,075,000$0$45.46M2.70%+$45.46M
Immatics N.V.SHS(IMTX)3,750,0006,275,000+2,525,000$42.79M$44.62M2.65%+$1.83M
KalVista Pharmaceuticals Inc4,000,0004,770,000+770,000$46.32M$40.40M2.40%-$5.92M
Geron Corporation(GERN)1,050,00011,000,000+9,950,000$4.77M$38.94M2.31%+$34.17M
Astria Therapeutics Inc4,000,0004,180,000+180,000$44.04M$37.37M2.22%-$6.67M
Arcellx Inc
COMMON STOCK
675,000475,000-200,000$56.37M$36.43M2.16%-$19.94M
SanofiADR(SNY)150,000750,000+600,000$8.64M$36.17M2.14%+$27.53M
GSK plcADR(GSK)300,0001,000,000+700,000$12.26M$33.82M2.01%+$21.56M
Savara Inc.(SVRA)8,090,00010,775,000+2,685,000$34.30M$33.08M1.96%-$1.22M
Xenon Pharmaceuticals Inc.(XENE)825,000810,000-15,000$32.48M$31.75M1.88%-$728.3K
Amicus Therapeutics Inc
COM
03,350,000+3,350,000$0$31.56M1.87%+$31.56M
AstraZeneca PLCADR(AZN)0475,000+475,000$0$31.12M1.85%+$31.12M
Sarepta Therapeutics, Inc.(SRPT)0250,000+250,000$0$30.40M1.80%+$30.40M
Madrigal Pharmaceuticals, Inc.(MDGL)30,00095,000+65,000$6.37M$29.31M1.74%+$22.95M
Globus Medical, Inc.CL A(GMED)0325,000+325,000$0$26.88M1.59%+$26.88M
Dianthus Therapeutics, Inc.(DNTH)395,0001,075,000+680,000$10.82M$23.43M1.39%+$12.62M
Nyxoah SASHS
SHS
02,924,216+2,924,216$0$23.39M1.39%+$23.39M
Verona Pharma PLCADS0495,000+495,000$0$22.99M1.36%+$22.99M
Ionis Pharmaceuticals, Inc.(IONS)0595,000+595,000$0$20.80M1.23%+$20.80M
Liquidia Corporation(LQDA)1,500,0001,760,000+260,000$15.00M$20.70M1.23%+$5.70M
Day One Biopharmaceuticals Inc
COM
2,500,0001,440,000-1,060,000$34.83M$18.24M1.08%-$16.58M
UroGen Pharma Ltd.(URGN)400,0001,630,000+1,230,000$5.08M$17.36M1.03%+$12.28M
Legend Biotech CorporationADS(LEGN)125,000475,000+350,000$6.09M$15.46M0.92%+$9.37M
Roivant Sciences Ltd.SHS(ROIV)01,250,000+1,250,000$0$14.79M0.88%+$14.79M
Regeneron Pharmaceuticals, Inc.(REGN)020,000+20,000$0$14.25M0.84%+$14.25M
Establishment Labs Holdings Inc.(ESTA)40,000300,000+260,000$1.73M$13.82M0.82%+$12.09M
Tyra Biosciences, Inc.(TYRA)0990,000+990,000$0$13.76M0.82%+$13.76M
Bicara Therapeutics Inc425,000710,000+285,000$10.82M$12.37M0.73%+$1.54M
Black Diamond Therapeutics Inc5,028,5005,600,000+571,500$21.87M$11.98M0.71%-$9.89M
Solid Biosciences Inc2,800,0002,850,000+50,000$19.52M$11.40M0.68%-$8.12M
Agilent Technologies, Inc.(A)100,00075,000-25,000$14.85M$10.08M0.60%-$4.77M
Applied Therapeutics Inc1,145,00011,500,000+10,355,000$9.73M$9.85M0.58%+$113.8K
Perrigo Company plcSHS(PRGO)0375,000+375,000$0$9.64M0.57%+$9.64M
Nurix Therapeutics, Inc.(NRIX)425,000485,000+60,000$9.55M$9.14M0.54%-$412.4K
Lexeo Therapeutics, Inc.(LXEO)850,0001,200,000+350,000$7.68M$7.90M0.47%+$212.0K
Zai Lab LimitedADR(ZLAB)0300,000+300,000$0$7.86M0.47%+$7.86M
Celldex Therapeutics, Inc.(CLDX)0305,000+305,000$0$7.71M0.46%+$7.71M
Voyager Therapeutics, Inc.(VYGR)490,0001,230,000+740,000$2.87M$6.97M0.41%+$4.11M
iTeos Therapeutics Inc1,025,000900,000-125,000$10.47M$6.91M0.41%-$3.55M
Intellia Therapeutics, Inc.(NTLA)0525,000+525,000$0$6.12M0.36%+$6.12M
OnKure Therapeutics, Inc.CL A(OKUR)0635,000+635,000$0$5.46M0.32%+$5.46M
Lakefront Biotherapeutics NVADR(LKFT)180,000180,0000$5.18M$4.95M0.29%-$232.2K
Chimerix Inc1,400,0001,400,0000$1.30M$4.87M0.29%+$3.57M
Sutro Biopharma, Inc.(STRO)02,570,000+2,570,000$0$4.73M0.28%+$4.73M
Ventyx Biosciences Inc1,725,0002,000,000+275,000$3.76M$4.38M0.26%+$619.5K
Fate Therapeutics, Inc.(FATE)1,685,0002,465,000+780,000$5.90M$4.07M0.24%-$1.83M
Alto Neuroscience, Inc.(ANRO)650,000915,000+265,000$7.44M$3.87M0.23%-$3.57M
Verve Therapeutics Inc525,000645,000+120,000$2.54M$3.64M0.22%+$1.10M
Passage Bio, Inc.(PASG)6,100,0006,100,0000$4.27M$3.46M0.21%-$810.7K
Allogene Therapeutics Inc1,500,0001,500,0000$4.20M$3.19M0.19%-$1.00M
TransMedics Group, Inc.(TMDX)050,000+50,000$0$3.12M0.18%+$3.12M
Monte Rosa Therapeutics, Inc.(GLUE)930,000425,000-505,000$4.93M$2.95M0.17%-$1.98M
Zymeworks Inc.(ZYME)615,000185,000-430,000$7.72M$2.71M0.16%-$5.01M
Engene Holdings Inc
COM
0370,000+370,000$0$2.46M0.15%+$2.46M
Bausch Health Cos Inc0250,000+250,000$0$2.02M0.12%+$2.02M
Neurogene Inc.(NGNE)080,000+80,000$0$1.83M0.11%+$1.83M
Achilles Therapeutics PLCADS1,500,0001,500,0000$1.53M$1.71M0.10%+$180.0K
Atara Biotherapeutics Inc124,677125,000+323$1.01M$1.66M0.10%+$650.1K
Immunovant, Inc.(IMVT)045,000+45,000$0$1.11M0.07%+$1.11M
MacroGenics, Inc.(MGNX)830,000280,000-550,000$2.73M$910.0K0.05%-$1.82M
Traws Pharma, Inc.(TRAW)075,000+75,000$0$666.0K0.04%+$666.0K
Tenax Therapeutics, Inc.(TENX)83,33355,189-28,144$288.3K$341.6K0.02%+$53.3K
Agios Pharmaceuticals, Inc.(AGIO)760,0000-760,000$33.77M$0—-$33.77M
Apogee Therapeutics Inc136,5000-136,500$8.02M$0—-$8.02M
Ardelyx Inc500,0000-500,000$3.44M$0—-$3.44M
Becton, Dickinson and Company(BDX)30,0000-30,000$7.23M$0—-$7.23M
Bristol-Myers Squibb Company(BMY)250,0000-250,000$12.94M$0—-$12.94M
Bruker Corporation(BRKR)125,0000-125,000$8.63M$0—-$8.63M
Crinetics Pharmaceuticals Inc205,0000-205,000$10.48M$0—-$10.48M
Edwards Lifesciences Corp275,0000-275,000$18.15M$0—-$18.15M
Gilead Sciences, Inc.(GILD)200,0000-200,000$16.77M$0—-$16.77M
Inari Medical Inc1,550,0000-1,550,000$63.92M$0—-$63.92M
Intra-Cellular Therapies Inc30,0000-30,000$2.20M$0—-$2.20M
Janux Therapeutics, Inc.(JANX)485,0000-485,000$22.03M$0—-$22.03M
Penumbra, Inc.(PEN)15,0000-15,000$2.91M$0—-$2.91M
Prime Medicine, Inc.(PRME)1,070,0000-1,070,000$4.14M$0—-$4.14M
PTC Therapeutics, Inc.(PTCT)80,0000-80,000$2.97M$0—-$2.97M
Relmada Therapeutics, Inc.(RLMD)490,0000-490,000$1.59M$0—-$1.59M
Reneo Pharmaceuticals Inc799,4000-799,400$1.36M$0—-$1.36M
Tarsus Pharmaceuticals, Inc.(TARS)230,0000-230,000$7.56M$0—-$7.56M
Zevra Therapeutics, Inc.(ZVRA)525,0000-525,000$3.64M$0—-$3.64M
Page 1 of 1
Vestal Point Capital, LP — 13F Holdings — Q4 2024 | TickerTrail